Fierce Biotech April 26, 2024
Conor Hale

Medtronic has secured FDA approval for its first closed-loop spinal cord stimulator, designed to take in signals from the body and adjust its therapy automatically.

The Inceptiv implant for chronic pain aims to keep pace with the body’s nerve activity as the patient goes through their daily life. According to the company, with traditional systems that deliver a constant level of mild electrical stimulation to disrupt pain signals, certain movements such as laughing, bending or sneezing may trigger periods of discomfort.

Medtronic said that Inceptiv SCS aims to sense the body’s response to stimulation via the spine’s evoked compound action potentials—noting changes as many as 50 times per second—while increasing or decreasing its dosage with the goal of maintaining its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

Share This Article